Shigella flexneri uses its type III secretion apparatus (TTSA) to inject host-altering proteins into targeted eukaryotic cells. The TTSA is composed of a basal body and an exposed needle with invasion plasmid antigen D (IpaD) forming a tip complex that controls secretion. The bile salt deoxycholate (DOC) stimulates recruitment of the translocator protein IpaB into the maturing TTSA needle tip complex. This process appears to be triggered by a direct interaction between DOC and IpaD. Fluorescence spectroscopy and NMR spectroscopy are used here to confirm the DOC−IpaD interaction and to reveal that IpaD conformational changes upon DOC binding trigger the appearance of IpaB at the needle tip. Förster resonance energy transfer between specific ...
Summary: Type III secretion apparatus (T3SA) are complex nanomachines that insert a translocation po...
This is the publisher's version, also available electronically from http://iai.asm.org/content/74/8/...
Shigella flexneri uses its type III secretion system (T3SS) to promote invasion of human intestinal ...
Type III secretion (TTS) is an essential virulence factor for Shigella flexneri, the causative agent...
Shigellosis (bacillary dysentery) results from infection by Shigella spp and represents one of the l...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Type III secretion (TTS) is an essential virulence function for Shigella flexneri that delivers effe...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
Many Gram-negative pathogens possess type III secretion systems as part of their required virulence ...
Shigella flexneri is a Gram-negative enteric pathogen that is the predominant cause of bacillary dys...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Shigella flexneri uses its type III secretion apparatus (TTSA) to deliver invasins into human cells....
The pathogenesis of Shigella flexneri requires a functional type III secretion apparatus to serve as...
Summary: Type III secretion apparatus (T3SA) are complex nanomachines that insert a translocation po...
This is the publisher's version, also available electronically from http://iai.asm.org/content/74/8/...
Shigella flexneri uses its type III secretion system (T3SS) to promote invasion of human intestinal ...
Type III secretion (TTS) is an essential virulence factor for Shigella flexneri, the causative agent...
Shigellosis (bacillary dysentery) results from infection by Shigella spp and represents one of the l...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Type III secretion (TTS) is an essential virulence function for Shigella flexneri that delivers effe...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
Many Gram-negative pathogens possess type III secretion systems as part of their required virulence ...
Shigella flexneri is a Gram-negative enteric pathogen that is the predominant cause of bacillary dys...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Shigella flexneri uses its type III secretion apparatus (TTSA) to deliver invasins into human cells....
The pathogenesis of Shigella flexneri requires a functional type III secretion apparatus to serve as...
Summary: Type III secretion apparatus (T3SA) are complex nanomachines that insert a translocation po...
This is the publisher's version, also available electronically from http://iai.asm.org/content/74/8/...
Shigella flexneri uses its type III secretion system (T3SS) to promote invasion of human intestinal ...